nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP1A1—head and neck cancer	0.65	1	CbGaD
Ticlopidine—CYP2D6—Hydroxyurea—head and neck cancer	0.0696	0.308	CbGbCtD
Ticlopidine—CYP2C8—Fluorouracil—head and neck cancer	0.0417	0.185	CbGbCtD
Ticlopidine—CYP1A2—Fluorouracil—head and neck cancer	0.0323	0.143	CbGbCtD
Ticlopidine—CYP2C9—Fluorouracil—head and neck cancer	0.0291	0.129	CbGbCtD
Ticlopidine—CYP2D6—Vinblastine—head and neck cancer	0.0246	0.109	CbGbCtD
Ticlopidine—CYP3A4—Vinblastine—head and neck cancer	0.0157	0.0694	CbGbCtD
Ticlopidine—CYP3A4—Docetaxel—head and neck cancer	0.0129	0.0572	CbGbCtD
Ticlopidine—Leukaemia—Hydroxyurea—head and neck cancer	0.00598	0.0823	CcSEcCtD
Ticlopidine—Lupus erythematosus—Hydroxyurea—head and neck cancer	0.00432	0.0595	CcSEcCtD
Ticlopidine—Diarrhoea haemorrhagic—Docetaxel—head and neck cancer	0.00331	0.0456	CcSEcCtD
Ticlopidine—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.00291	0.04	CcSEcCtD
Ticlopidine—Peptic ulcer—Vinblastine—head and neck cancer	0.00264	0.0364	CcSEcCtD
Ticlopidine—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00239	0.0328	CcSEcCtD
Ticlopidine—Lupus erythematosus—Docetaxel—head and neck cancer	0.00225	0.0309	CcSEcCtD
Ticlopidine—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00151	0.0208	CcSEcCtD
Ticlopidine—Hepatic failure—Hydroxyurea—head and neck cancer	0.0013	0.0179	CcSEcCtD
Ticlopidine—Pancytopenia—Vinblastine—head and neck cancer	0.00105	0.0145	CcSEcCtD
Ticlopidine—Sepsis—Fluorouracil—head and neck cancer	0.00101	0.0138	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000968	0.0133	CcSEcCtD
Ticlopidine—Pancytopenia—Hydroxyurea—head and neck cancer	0.00096	0.0132	CcSEcCtD
Ticlopidine—Haemoglobin—Vinblastine—head and neck cancer	0.000891	0.0123	CcSEcCtD
Ticlopidine—Haemorrhage—Vinblastine—head and neck cancer	0.000887	0.0122	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000883	0.0122	CcSEcCtD
Ticlopidine—Osteoarthritis—Fluorouracil—head and neck cancer	0.000842	0.0116	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000842	0.0116	CcSEcCtD
Ticlopidine—Haemoglobin—Hydroxyurea—head and neck cancer	0.000813	0.0112	CcSEcCtD
Ticlopidine—Haemorrhage—Hydroxyurea—head and neck cancer	0.000809	0.0111	CcSEcCtD
Ticlopidine—Colitis—Docetaxel—head and neck cancer	0.000803	0.0111	CcSEcCtD
Ticlopidine—Sepsis—Docetaxel—head and neck cancer	0.000726	0.00999	CcSEcCtD
Ticlopidine—Eosinophilia—Fluorouracil—head and neck cancer	0.00072	0.00991	CcSEcCtD
Ticlopidine—Pancytopenia—Fluorouracil—head and neck cancer	0.000691	0.00951	CcSEcCtD
Ticlopidine—Hepatic failure—Docetaxel—head and neck cancer	0.000676	0.0093	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000636	0.00875	CcSEcCtD
Ticlopidine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000617	0.00849	CcSEcCtD
Ticlopidine—Epistaxis—Fluorouracil—head and neck cancer	0.000612	0.00842	CcSEcCtD
Ticlopidine—Hyponatraemia—Docetaxel—head and neck cancer	0.00061	0.00839	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000607	0.00836	CcSEcCtD
Ticlopidine—Anorexia—Vinblastine—head and neck cancer	0.000601	0.00827	CcSEcCtD
Ticlopidine—Haemoglobin—Fluorouracil—head and neck cancer	0.000585	0.00805	CcSEcCtD
Ticlopidine—Haemorrhage—Fluorouracil—head and neck cancer	0.000582	0.00801	CcSEcCtD
Ticlopidine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000563	0.00774	CcSEcCtD
Ticlopidine—Liver function test abnormal—Docetaxel—head and neck cancer	0.000561	0.00772	CcSEcCtD
Ticlopidine—Anorexia—Hydroxyurea—head and neck cancer	0.000548	0.00754	CcSEcCtD
Ticlopidine—Decreased appetite—Vinblastine—head and neck cancer	0.000548	0.00754	CcSEcCtD
Ticlopidine—Cramp muscle—Docetaxel—head and neck cancer	0.000547	0.00753	CcSEcCtD
Ticlopidine—Pain—Vinblastine—head and neck cancer	0.000539	0.00742	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000515	0.00709	CcSEcCtD
Ticlopidine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000506	0.00696	CcSEcCtD
Ticlopidine—Decreased appetite—Hydroxyurea—head and neck cancer	0.0005	0.00687	CcSEcCtD
Ticlopidine—Pancytopenia—Docetaxel—head and neck cancer	0.000499	0.00686	CcSEcCtD
Ticlopidine—Pain—Hydroxyurea—head and neck cancer	0.000491	0.00676	CcSEcCtD
Ticlopidine—Hypersensitivity—Vinblastine—head and neck cancer	0.000464	0.00639	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000464	0.00639	CcSEcCtD
Ticlopidine—Renal failure—Docetaxel—head and neck cancer	0.00046	0.00633	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000459	0.00631	CcSEcCtD
Ticlopidine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000454	0.00625	CcSEcCtD
Ticlopidine—Asthenia—Vinblastine—head and neck cancer	0.000452	0.00622	CcSEcCtD
Ticlopidine—Epistaxis—Docetaxel—head and neck cancer	0.000441	0.00608	CcSEcCtD
Ticlopidine—Myalgia—Fluorouracil—head and neck cancer	0.000431	0.00594	CcSEcCtD
Ticlopidine—Diarrhoea—Vinblastine—head and neck cancer	0.000431	0.00593	CcSEcCtD
Ticlopidine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000423	0.00583	CcSEcCtD
Ticlopidine—Haemoglobin—Docetaxel—head and neck cancer	0.000422	0.00581	CcSEcCtD
Ticlopidine—Haemorrhage—Docetaxel—head and neck cancer	0.00042	0.00578	CcSEcCtD
Ticlopidine—Hepatitis—Docetaxel—head and neck cancer	0.00042	0.00578	CcSEcCtD
Ticlopidine—Dizziness—Vinblastine—head and neck cancer	0.000417	0.00573	CcSEcCtD
Ticlopidine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000414	0.00569	CcSEcCtD
Ticlopidine—Asthenia—Hydroxyurea—head and neck cancer	0.000412	0.00567	CcSEcCtD
Ticlopidine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000405	0.00557	CcSEcCtD
Ticlopidine—Vomiting—Vinblastine—head and neck cancer	0.000401	0.00551	CcSEcCtD
Ticlopidine—Erythema multiforme—Docetaxel—head and neck cancer	0.000397	0.00547	CcSEcCtD
Ticlopidine—Headache—Vinblastine—head and neck cancer	0.000395	0.00543	CcSEcCtD
Ticlopidine—Anorexia—Fluorouracil—head and neck cancer	0.000394	0.00543	CcSEcCtD
Ticlopidine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000393	0.00541	CcSEcCtD
Ticlopidine—Dizziness—Hydroxyurea—head and neck cancer	0.00038	0.00523	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000377	0.00519	CcSEcCtD
Ticlopidine—Nausea—Vinblastine—head and neck cancer	0.000374	0.00515	CcSEcCtD
Ticlopidine—Vomiting—Hydroxyurea—head and neck cancer	0.000365	0.00503	CcSEcCtD
Ticlopidine—Dyspepsia—Fluorouracil—head and neck cancer	0.000364	0.00501	CcSEcCtD
Ticlopidine—Rash—Hydroxyurea—head and neck cancer	0.000362	0.00499	CcSEcCtD
Ticlopidine—Dermatitis—Hydroxyurea—head and neck cancer	0.000362	0.00498	CcSEcCtD
Ticlopidine—Headache—Hydroxyurea—head and neck cancer	0.00036	0.00495	CcSEcCtD
Ticlopidine—Decreased appetite—Fluorouracil—head and neck cancer	0.00036	0.00495	CcSEcCtD
Ticlopidine—Pain—Fluorouracil—head and neck cancer	0.000354	0.00487	CcSEcCtD
Ticlopidine—Muscle spasms—Docetaxel—head and neck cancer	0.000352	0.00484	CcSEcCtD
Ticlopidine—Nausea—Hydroxyurea—head and neck cancer	0.000341	0.0047	CcSEcCtD
Ticlopidine—Urticaria—Fluorouracil—head and neck cancer	0.000329	0.00452	CcSEcCtD
Ticlopidine—Body temperature increased—Fluorouracil—head and neck cancer	0.000327	0.0045	CcSEcCtD
Ticlopidine—Arthralgia—Docetaxel—head and neck cancer	0.000311	0.00429	CcSEcCtD
Ticlopidine—Myalgia—Docetaxel—head and neck cancer	0.000311	0.00429	CcSEcCtD
Ticlopidine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000305	0.00419	CcSEcCtD
Ticlopidine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000299	0.00411	CcSEcCtD
Ticlopidine—Pruritus—Fluorouracil—head and neck cancer	0.000293	0.00403	CcSEcCtD
Ticlopidine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000292	0.00402	CcSEcCtD
Ticlopidine—Anorexia—Docetaxel—head and neck cancer	0.000285	0.00392	CcSEcCtD
Ticlopidine—Diarrhoea—Fluorouracil—head and neck cancer	0.000283	0.00389	CcSEcCtD
Ticlopidine—Dizziness—Fluorouracil—head and neck cancer	0.000274	0.00376	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000272	0.00374	CcSEcCtD
Ticlopidine—Vomiting—Fluorouracil—head and neck cancer	0.000263	0.00362	CcSEcCtD
Ticlopidine—Dyspepsia—Docetaxel—head and neck cancer	0.000263	0.00362	CcSEcCtD
Ticlopidine—Rash—Fluorouracil—head and neck cancer	0.000261	0.00359	CcSEcCtD
Ticlopidine—Dermatitis—Fluorouracil—head and neck cancer	0.000261	0.00359	CcSEcCtD
Ticlopidine—Decreased appetite—Docetaxel—head and neck cancer	0.00026	0.00357	CcSEcCtD
Ticlopidine—Headache—Fluorouracil—head and neck cancer	0.000259	0.00357	CcSEcCtD
Ticlopidine—Pain—Docetaxel—head and neck cancer	0.000255	0.00351	CcSEcCtD
Ticlopidine—Nausea—Fluorouracil—head and neck cancer	0.000246	0.00338	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000244	0.00336	CcSEcCtD
Ticlopidine—Body temperature increased—Docetaxel—head and neck cancer	0.000236	0.00325	CcSEcCtD
Ticlopidine—Hypersensitivity—Docetaxel—head and neck cancer	0.00022	0.00303	CcSEcCtD
Ticlopidine—Asthenia—Docetaxel—head and neck cancer	0.000214	0.00295	CcSEcCtD
Ticlopidine—Pruritus—Docetaxel—head and neck cancer	0.000211	0.00291	CcSEcCtD
Ticlopidine—Diarrhoea—Docetaxel—head and neck cancer	0.000204	0.00281	CcSEcCtD
Ticlopidine—Dizziness—Docetaxel—head and neck cancer	0.000197	0.00272	CcSEcCtD
Ticlopidine—Vomiting—Docetaxel—head and neck cancer	0.00019	0.00261	CcSEcCtD
Ticlopidine—Rash—Docetaxel—head and neck cancer	0.000188	0.00259	CcSEcCtD
Ticlopidine—Dermatitis—Docetaxel—head and neck cancer	0.000188	0.00259	CcSEcCtD
Ticlopidine—Headache—Docetaxel—head and neck cancer	0.000187	0.00257	CcSEcCtD
Ticlopidine—Nausea—Docetaxel—head and neck cancer	0.000177	0.00244	CcSEcCtD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000138	0.00268	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000134	0.0026	CbGpPWpGaD
Ticlopidine—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.00013	0.00252	CbGpPWpGaD
Ticlopidine—CYP1A1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000129	0.00251	CbGpPWpGaD
Ticlopidine—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000129	0.0025	CbGpPWpGaD
Ticlopidine—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000128	0.00249	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000128	0.00248	CbGpPWpGaD
Ticlopidine—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000127	0.00246	CbGpPWpGaD
Ticlopidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000124	0.00242	CbGpPWpGaD
Ticlopidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00012	0.00232	CbGpPWpGaD
Ticlopidine—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000118	0.0023	CbGpPWpGaD
Ticlopidine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000118	0.00229	CbGpPWpGaD
Ticlopidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000114	0.00222	CbGpPWpGaD
Ticlopidine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000114	0.00222	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000114	0.00221	CbGpPWpGaD
Ticlopidine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000113	0.0022	CbGpPWpGaD
Ticlopidine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.00011	0.00214	CbGpPWpGaD
Ticlopidine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000109	0.00213	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000109	0.00211	CbGpPWpGaD
Ticlopidine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000108	0.00211	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000108	0.00209	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—KISS1—head and neck cancer	0.000107	0.00207	CbGpPWpGaD
Ticlopidine—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000106	0.00205	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000102	0.00199	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	9.78e-05	0.0019	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	9.78e-05	0.0019	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	9.78e-05	0.0019	CbGpPWpGaD
Ticlopidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.69e-05	0.00188	CbGpPWpGaD
Ticlopidine—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.63e-05	0.00187	CbGpPWpGaD
Ticlopidine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	9.29e-05	0.0018	CbGpPWpGaD
Ticlopidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	9.23e-05	0.00179	CbGpPWpGaD
Ticlopidine—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	9.23e-05	0.00179	CbGpPWpGaD
Ticlopidine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.11e-05	0.00177	CbGpPWpGaD
Ticlopidine—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	9.1e-05	0.00177	CbGpPWpGaD
Ticlopidine—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	9.04e-05	0.00175	CbGpPWpGaD
Ticlopidine—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	8.91e-05	0.00173	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	8.88e-05	0.00172	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	8.8e-05	0.00171	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—GRP—head and neck cancer	8.77e-05	0.0017	CbGpPWpGaD
Ticlopidine—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	8.75e-05	0.0017	CbGpPWpGaD
Ticlopidine—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	8.63e-05	0.00167	CbGpPWpGaD
Ticlopidine—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	8.57e-05	0.00166	CbGpPWpGaD
Ticlopidine—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	8.52e-05	0.00165	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—STAT6—head and neck cancer	8.52e-05	0.00165	CbGpPWpGaD
Ticlopidine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	8.49e-05	0.00165	CbGpPWpGaD
Ticlopidine—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	8.45e-05	0.00164	CbGpPWpGaD
Ticlopidine—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	8.4e-05	0.00163	CbGpPWpGaD
Ticlopidine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	8.37e-05	0.00163	CbGpPWpGaD
Ticlopidine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	8.23e-05	0.0016	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	8.15e-05	0.00158	CbGpPWpGaD
Ticlopidine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	7.85e-05	0.00152	CbGpPWpGaD
Ticlopidine—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	7.81e-05	0.00152	CbGpPWpGaD
Ticlopidine—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	7.7e-05	0.0015	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—UROD—head and neck cancer	7.69e-05	0.00149	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—YAP1—head and neck cancer	7.54e-05	0.00146	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—UROD—head and neck cancer	7.53e-05	0.00146	CbGpPWpGaD
Ticlopidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.48e-05	0.00145	CbGpPWpGaD
Ticlopidine—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	7.4e-05	0.00144	CbGpPWpGaD
Ticlopidine—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	7.3e-05	0.00142	CbGpPWpGaD
Ticlopidine—P2RY12—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	7.25e-05	0.00141	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—UROD—head and neck cancer	7.1e-05	0.00138	CbGpPWpGaD
Ticlopidine—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	6.97e-05	0.00135	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	6.93e-05	0.00135	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—IL2—head and neck cancer	6.9e-05	0.00134	CbGpPWpGaD
Ticlopidine—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	6.88e-05	0.00134	CbGpPWpGaD
Ticlopidine—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	6.61e-05	0.00128	CbGpPWpGaD
Ticlopidine—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	6.52e-05	0.00127	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—UROD—head and neck cancer	6.51e-05	0.00126	CbGpPWpGaD
Ticlopidine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	6.41e-05	0.00125	CbGpPWpGaD
Ticlopidine—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	6.36e-05	0.00123	CbGpPWpGaD
Ticlopidine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	6.32e-05	0.00123	CbGpPWpGaD
Ticlopidine—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	6.27e-05	0.00122	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	6.24e-05	0.00121	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	6.24e-05	0.00121	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	6.24e-05	0.00121	CbGpPWpGaD
Ticlopidine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	6.08e-05	0.00118	CbGpPWpGaD
Ticlopidine—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	6.03e-05	0.00117	CbGpPWpGaD
Ticlopidine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	6e-05	0.00116	CbGpPWpGaD
Ticlopidine—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	5.94e-05	0.00115	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—VEGFA—head and neck cancer	5.86e-05	0.00114	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—UROD—head and neck cancer	5.81e-05	0.00113	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—MAPK3—head and neck cancer	5.54e-05	0.00108	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.51e-05	0.00107	CbGpPWpGaD
Ticlopidine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	5.43e-05	0.00105	CbGpPWpGaD
Ticlopidine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	5.36e-05	0.00104	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—UROD—head and neck cancer	5.35e-05	0.00104	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—UROD—head and neck cancer	5.3e-05	0.00103	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—MAPK1—head and neck cancer	5.27e-05	0.00102	CbGpPWpGaD
Ticlopidine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	5.15e-05	0.001	CbGpPWpGaD
Ticlopidine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	5.08e-05	0.000986	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.05e-05	0.000981	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	5.01e-05	0.000972	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—PIK3CA—head and neck cancer	4.58e-05	0.000889	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—UROD—head and neck cancer	4.53e-05	0.000879	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.51e-05	0.000876	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—TP53—head and neck cancer	4.43e-05	0.00086	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—IL2—head and neck cancer	4.36e-05	0.000846	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—HRAS—head and neck cancer	4.23e-05	0.000822	CbGpPWpGaD
Ticlopidine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	4.19e-05	0.000814	CbGpPWpGaD
Ticlopidine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	4.13e-05	0.000803	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.11e-05	0.000799	CbGpPWpGaD
Ticlopidine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	3.97e-05	0.000772	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—IL2—head and neck cancer	3.96e-05	0.000768	CbGpPWpGaD
Ticlopidine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	3.92e-05	0.000761	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—AKT1—head and neck cancer	3.74e-05	0.000726	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.51e-05	0.000682	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—UROD—head and neck cancer	3.5e-05	0.000679	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NOTCH1—head and neck cancer	3.4e-05	0.00066	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—NAT2—head and neck cancer	3.19e-05	0.00062	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—MAPK3—head and neck cancer	3.18e-05	0.000618	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.13e-05	0.000608	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—NAT2—head and neck cancer	3.13e-05	0.000608	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—MAPK1—head and neck cancer	3.03e-05	0.000588	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—EGFR—head and neck cancer	3.03e-05	0.000588	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—NAT2—head and neck cancer	2.95e-05	0.000573	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—PIK3CA—head and neck cancer	2.89e-05	0.000562	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.87e-05	0.000558	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.84e-05	0.000552	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—DPYD—head and neck cancer	2.8e-05	0.000544	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—DPYD—head and neck cancer	2.74e-05	0.000533	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NAT2—head and neck cancer	2.7e-05	0.000525	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—YAP1—head and neck cancer	2.66e-05	0.000516	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—PIK3CA—head and neck cancer	2.63e-05	0.00051	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—YAP1—head and neck cancer	2.6e-05	0.000506	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—DPYD—head and neck cancer	2.59e-05	0.000502	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.56e-05	0.000498	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.54e-05	0.000493	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—YAP1—head and neck cancer	2.45e-05	0.000477	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—HRAS—head and neck cancer	2.43e-05	0.000472	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NAT2—head and neck cancer	2.41e-05	0.000469	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—DPYD—head and neck cancer	2.37e-05	0.00046	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—AKT1—head and neck cancer	2.36e-05	0.000459	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL2—head and neck cancer	2.34e-05	0.000454	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.34e-05	0.000454	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.31e-05	0.000449	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCND1—head and neck cancer	2.28e-05	0.000442	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—YAP1—head and neck cancer	2.25e-05	0.000437	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NAT2—head and neck cancer	2.22e-05	0.000431	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NAT2—head and neck cancer	2.2e-05	0.000427	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PTEN—head and neck cancer	2.2e-05	0.000427	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—AKT1—head and neck cancer	2.15e-05	0.000417	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—DPYD—head and neck cancer	2.12e-05	0.000411	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—YAP1—head and neck cancer	2.01e-05	0.00039	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2e-05	0.000388	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—VEGFA—head and neck cancer	1.99e-05	0.000386	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.98e-05	0.000384	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—STAT3—head and neck cancer	1.97e-05	0.000382	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—DPYD—head and neck cancer	1.95e-05	0.000378	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—DPYD—head and neck cancer	1.93e-05	0.000375	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NAT2—head and neck cancer	1.88e-05	0.000365	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MAPK3—head and neck cancer	1.88e-05	0.000365	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—YAP1—head and neck cancer	1.85e-05	0.000359	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.84e-05	0.000358	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—YAP1—head and neck cancer	1.83e-05	0.000356	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MAPK1—head and neck cancer	1.79e-05	0.000347	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EGFR—head and neck cancer	1.79e-05	0.000347	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.69e-05	0.000328	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—DPYD—head and neck cancer	1.65e-05	0.00032	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.61e-05	0.000312	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—TYMS—head and neck cancer	1.6e-05	0.00031	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GSTM1—head and neck cancer	1.58e-05	0.000306	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—YAP1—head and neck cancer	1.57e-05	0.000304	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—TYMS—head and neck cancer	1.56e-05	0.000304	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CA—head and neck cancer	1.55e-05	0.000301	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GSTM1—head and neck cancer	1.55e-05	0.0003	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GPX1—head and neck cancer	1.51e-05	0.000293	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.51e-05	0.000293	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TP53—head and neck cancer	1.5e-05	0.000291	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.5e-05	0.00029	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GPX1—head and neck cancer	1.48e-05	0.000287	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.47e-05	0.000286	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—TYMS—head and neck cancer	1.47e-05	0.000286	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP1A1—head and neck cancer	1.46e-05	0.000284	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GSTM1—head and neck cancer	1.46e-05	0.000283	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NAT2—head and neck cancer	1.45e-05	0.000282	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HRAS—head and neck cancer	1.44e-05	0.000279	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GPX1—head and neck cancer	1.4e-05	0.000271	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.38e-05	0.000267	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—TYMS—head and neck cancer	1.35e-05	0.000262	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.34e-05	0.000259	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.32e-05	0.000256	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GPX1—head and neck cancer	1.28e-05	0.000248	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—DPYD—head and neck cancer	1.27e-05	0.000247	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—AKT1—head and neck cancer	1.27e-05	0.000246	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.27e-05	0.000246	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—YAP1—head and neck cancer	1.21e-05	0.000235	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—TYMS—head and neck cancer	1.21e-05	0.000234	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.2e-05	0.000233	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.19e-05	0.000231	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.18e-05	0.000228	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GPX1—head and neck cancer	1.14e-05	0.000222	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.13e-05	0.00022	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.13e-05	0.000219	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TYMS—head and neck cancer	1.11e-05	0.000215	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TYMS—head and neck cancer	1.1e-05	0.000214	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.1e-05	0.000213	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.09e-05	0.000211	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GPX1—head and neck cancer	1.05e-05	0.000204	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GPX1—head and neck cancer	1.04e-05	0.000202	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.04e-05	0.000202	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.04e-05	0.000202	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.03e-05	0.0002	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.03e-05	0.000199	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TYMS—head and neck cancer	9.4e-06	0.000182	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTM1—head and neck cancer	9.29e-06	0.00018	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.29e-06	0.00018	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GPX1—head and neck cancer	8.9e-06	0.000173	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTGS2—head and neck cancer	8.89e-06	0.000173	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	8.81e-06	0.000171	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTGS2—head and neck cancer	8.71e-06	0.000169	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.47e-06	0.000164	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTGS2—head and neck cancer	8.21e-06	0.000159	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTEN—head and neck cancer	7.76e-06	0.000151	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTEN—head and neck cancer	7.6e-06	0.000148	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTGS2—head and neck cancer	7.53e-06	0.000146	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TYMS—head and neck cancer	7.25e-06	0.000141	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.23e-06	0.00014	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTM1—head and neck cancer	7.17e-06	0.000139	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTEN—head and neck cancer	7.16e-06	0.000139	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GPX1—head and neck cancer	6.87e-06	0.000133	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	6.8e-06	0.000132	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTGS2—head and neck cancer	6.72e-06	0.000131	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTEN—head and neck cancer	6.57e-06	0.000128	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTGS2—head and neck cancer	6.18e-06	0.00012	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTGS2—head and neck cancer	6.13e-06	0.000119	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTEN—head and neck cancer	5.86e-06	0.000114	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	5.47e-06	0.000106	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTEN—head and neck cancer	5.39e-06	0.000105	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CA—head and neck cancer	5.36e-06	0.000104	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTEN—head and neck cancer	5.34e-06	0.000104	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTGS2—head and neck cancer	5.24e-06	0.000102	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CA—head and neck cancer	5.05e-06	9.81e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	4.63e-06	9e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTEN—head and neck cancer	4.57e-06	8.87e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKT1—head and neck cancer	4.47e-06	8.68e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKT1—head and neck cancer	4.38e-06	8.5e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	4.14e-06	8.03e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKT1—head and neck cancer	4.13e-06	8.02e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.04e-06	7.85e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	3.8e-06	7.38e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKT1—head and neck cancer	3.78e-06	7.35e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	3.77e-06	7.32e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTEN—head and neck cancer	3.52e-06	6.84e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKT1—head and neck cancer	3.38e-06	6.56e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.22e-06	6.26e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKT1—head and neck cancer	3.11e-06	6.03e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKT1—head and neck cancer	3.08e-06	5.98e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKT1—head and neck cancer	2.63e-06	5.11e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.49e-06	4.83e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKT1—head and neck cancer	2.03e-06	3.94e-05	CbGpPWpGaD
